- Sputnik International
Russia
The latest news and stories from Russia. Stay tuned for updates and breaking news on defense, politics, economy and more.

Russia Will Start Mass Vaccination of People Vulnerable to COVID-19 in November or December

© Russian Defence Ministry / Go to the mediabankIn this handout photo released by the Russian Defence Ministry, a medical worker wearing protective gear conducts daily rounds with a participant in a coronavirus vaccine trial during tests at the Burdenko Main Military Clinical Hospital in Moscow, Russia
In this handout photo released by the Russian Defence Ministry, a medical worker wearing protective gear conducts daily rounds with a participant in a coronavirus vaccine trial during tests at the Burdenko Main Military Clinical Hospital in Moscow, Russia - Sputnik International
Subscribe
On 11 August, the Russian government officially registered Sputnik V as the world's first vaccine against COVID-19.

Russian Health Minister Mikhail Murashko said that Russia will launch the large-scale vaccination of people who are especially vulnerable to COVID-19 in November or December.

"For risk groups, the first vaccines will begin to arrive in small quantities as early as September, and more massive vaccination coverage is planned after November-December," the minister said.

Post-registration trial of the COVID-19 vaccine will begin this week, he added.

"This week, post-registration clinical trials begin; groups of volunteers totaling 40 thousand people have been recruited. These are placebo-controlled studies that will allow us to track all the nuances and details, including in a large population. We see that the vaccine is effective and safe," Murashko said.

In August, the Russian government officially registered Sputnik V as the world's first vaccine against COVID-19. Though the vaccine is still underway with the third — last — phase of clinical trials, as per the protocols of the World Health Organization, Russian health officials said it had proven the capability to produce stable immunity against the coronavirus.

Several other countries have followed the lead and announced they would fast-track the registration of their COVID-19 vaccines for emergency use.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала